Vir Biotechnology, Inc. (VIR)
8.71
-0.06
(-0.68%)
USD |
NASDAQ |
May 19, 12:58
Vir Biotechnology Shareholders Equity (Quarterly) : 812.76M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| Krystal Biotech, Inc. | 1.277B |
| Gossamer Bio, Inc. | -161.48M |
| Sensei Biotherapeutics, Inc. | 23.01M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.026B |
| Total Liabilities (Quarterly) | 212.82M |
| Debt to Equity Ratio | 0.1176 |
| Current Ratio | 7.110 |
| Net Debt Paydown Yield | 0.03% |